Advantage Trust Company’s Sanofi SNY Stock Holding History

Advantage Trust Company’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-43	Closed	-$2.07K	–	186
2024 Q4	$2.07K	Buy	+43	New	+$2.19K	﹤0.01%	178

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Advantage Trust Company's SNY Position: Q1 2025 in Review

Advantage Trust Company sold out of Sanofi (SNY) in Q1 2025, closing a stake of 43 shares — an estimated $2.07K sold.

Advantage Trust Company first reported a position in SNY in Q4 2024 and held it in 1 quarter. The position peaked at $2.07K in Q4 2024. 771 funds tracked by Wall St. Rank hold SNY as of Q1 2025.

Advantage Trust Company reported no remaining Sanofi position as of Q1 2025 after selling out during the quarter.
Advantage Trust Company sold 43 Sanofi shares in Q1 2025, an estimated $2.07K.
Advantage Trust Company first reported a position in Sanofi in Q4 2024 and held it in 1 quarter.
Advantage Trust Company's Sanofi position peaked at $2.07K in Q4 2024.
771 funds tracked by Wall St. Rank held Sanofi as of Q1 2025.

Based on Advantage Trust Company's 13F filing for Q1 2025, filed 7 May 2025.